Search

Search Constraints

You searched for: Author/Creator Papandreou, Christos

Search Results

3. Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial. Issue 12 (December 2020)

6. Regional differences in sorafenib‐treated patients with hepatocellular carcinoma: GIDEON observational study. (1st April 2016)